regarding funding and awareness of rare cancers
2025 · 1st Quarter (Jan 1 - Mar 31)
SHEPHERD THERAPEUTICS
Filed by G2G CONSULTING.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 21, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- G2G CONSULTING
- Client
- SHEPHERD THERAPEUTICS
- Filing UUID
- 25681f6b-df51-4927-a5ae-be545ed22847
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
regarding funding and awareness of rare cancers
regarding funding and awareness of rare cancers
regarding funding and awareness of rare cancers
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.